US FDA approved Aurobindo Pharma to produce generic AIDS drug

by Medindia Content Team on  December 26, 2005 at 8:59 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

US FDA approved Aurobindo Pharma to produce generic AIDS drug
The US Food and Drug Association (FDA) has approved Aurobindo Pharma Limited to produce the generic version of oral Stavudine solution 1 mg/mL, which is used in children for control of HIV treatment. Zerit (Stavudine Oral solution) is produced commercially by Bristol-Myers Squibb which has the patent for the drug which is found to be very effective against HIV. Stavudine is a synthetic thymidine nucleoside analogue. The generic version approved for Aurobindo pharma manufacture could be given in HIV treatment to children's from childhood to adolescent age. The drug Stavudine acts by inhibiting the cell division of the HIV by inhibiting its reverse transcriptase enzyme which is required for the virus replication. Aurobindo Pharmaceuticals is present in India which is involved in the manufacturing of generic and active pharmaceutical drugs.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Oral Health And AIDS Drug Toxicity AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs AIDS - Initial Theories and Disease Progression 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive